Alvotech, Advanz Pharma to commercialize 5 proposed biosimilars in EuropeThe partnership agreement includes proposed biosimilars to Simponi, Entyvio and three additional early-stage undisclosed biosimilar candidates. Endo to distribute bivalirudin injection in ready-to-use vialsEndo will commercialize the product through its Par sterile products business and expects to begin shipping in summer 2023. Celltrion USA obtains FDA nod for Humira biosimilar Yuflyma is FDA-approved to treat eight conditions, including Crohn’s disease and ulcerative colitis. Aurobindo receives nod for generic Millipred Prednisolone tablets are indicated for a wide variety of disorders. Amneal launches Fylnetra biosimilar Fylnetra is used to treat neutropenia, which is commonly experienced by patients undergoing chemotherapy. Upsher-Smith intros dicyclomine hydrochloride capsules Upsher-Smith now offers dicyclomine hydrochloride in tablet and capsule forms. U.S. Supreme Court rejects Teva challenge to $235M GSK award in patent dispute over generic drugs involving Coreg The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report. Aurobindo receives FDA nod for generic Dibenzyline Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. Aurigene Pharmaceutical Services expands biologics CDMO capacity Aurigene is investing $40 million in an R&D and pilot scale facility as a first step toward a series of strategic investments. Alembic intros Docetaxel injection Docetaxel injection is a microtubule inhibitor indicated for treating patients with several types of cancer after failure of prior chemotherapy. First Previous 56 57 58 59 60 Next Last
